Opus Genetics (IRD) Free Cash Flow Growth (5y) (2015 - 2026)
Opus Genetics (IRD) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | Opus Genetics | 293.68 Mn | 233.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.97% |
| Dec 31, 2025 | -17.67% |
| Sep 30, 2025 | -42.28% |
| Jun 30, 2025 | -73.62% |
| Mar 31, 2025 | -65.15% |
| Dec 31, 2024 | -28.46% |
| Sep 30, 2024 | -16.62% |
| Jun 30, 2024 | -32.10% |
| Mar 31, 2024 | -5.40% |
| Dec 31, 2023 | 24.44% |
| Sep 30, 2023 | 6.50% |
| Jun 30, 2023 | 17.31% |
| Mar 31, 2023 | 8.23% |
| Dec 31, 2022 | 57.40% |
| Sep 30, 2022 | -5.44% |
| Jun 30, 2022 | 1.52% |
| Mar 31, 2022 | -8.14% |
| Dec 31, 2021 | -30.46% |
| Sep 30, 2021 | -2.80% |
| Jun 30, 2021 | 3.10% |